Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
Phase 2
Completed
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2002-11-04
- Last Posted Date
- 2010-04-27
- Target Recruit Count
- 88
- Registration Number
- NCT00048503
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Phase 3
Completed
- Conditions
- Depressive DisorderDepressive Disorder, MajorDepression
- First Posted Date
- 2002-09-05
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 258
- Registration Number
- NCT00044681
A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat
Phase 3
Completed
- Conditions
- Otitis Media
- First Posted Date
- 2002-09-04
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 206
- Registration Number
- NCT00044473
A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
Phase 3
Completed
- Conditions
- BronchitisChronic Bronchitis
- First Posted Date
- 2002-08-07
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 659
- Registration Number
- NCT00042718
A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
Phase 3
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2002-05-21
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 434
- Registration Number
- NCT00037674
Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery
Phase 3
Completed
- Conditions
- Stomach NeoplasmsRectal Neoplasms
- First Posted Date
- 2002-05-10
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 60
- Registration Number
- NCT00036400
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
Phase 3
Completed
- Conditions
- Bipolar DisorderAffective Disorders, PsychoticMood DisordersMental Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2002-05-07
- Last Posted Date
- 2011-06-27
- Target Recruit Count
- 13
- Registration Number
- NCT00035802
Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
Phase 3
Completed
- Conditions
- DementiaAlzheimer DiseaseMental Disorders
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-02-01
- Target Recruit Count
- 473
- Registration Number
- NCT00034762
A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Phase 3
Completed
- Conditions
- SchizophreniaPsychotic Disorders
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-01-10
- Target Recruit Count
- 141
- Registration Number
- NCT00034775
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
Phase 3
Completed
- Conditions
- Dementia, Vascular
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 254
- Registration Number
- NCT00035191
© Copyright 2025. All Rights Reserved by MedPath